Overview of the CD38 antibody in multiple myeloma

Bookmark and Share
Published: 1 Nov 2016
Views: 2315
Dr Torben Plesner - Vejle Hospital, Vejle, Denmark

Dr Plesner talks to ecancertv at ICMM 2016 about the use of CD38 monoclonal antibodies for patients with multiple myeloma.

For more on this topic, see our interview with Dr Van De Donk and Prof Mateos. Interivew with Prof Moreau coming soon.

ecancer's filming at ICMM 2016 has been kindly supported by Amgen through the ECMS Foundation. ecancer is editorially independent and there is no influence over content.